EDA-HPVE7

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameEDA-HPVE7
Drug Alias NameEDA-HPVE7 fusion protein vaccine (Digna Biotech)EDA-HPVE7
ClassificationVaccines > Application > Therapeutic vaccineBiologics > Protein drugs > Recombinant protein > Fusion proteinVaccines > Development/production technology > Inactivated vaccine > Subunit vaccine
Mechanisms of ActionToll like receptor 4 agonists
TargetsToll like receptor 4
Therapy Area/IndicationsUterine Cervical Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCenter for Applied Medical Research
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCenter for Applied Medical ResearchDigna Biotech Sl
Active IndicationsN/A
Inactive IndicationsUterine Cervical Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A